Human lung carcinomas synthesize immunoregulatory glucocorticoids

The need for new options in lung cancer treatment inevitably leads back to basic research. The tumor itself and the tumor environment especially the interaction with the immune system need to be better understood to develop targeted therapies. In the context of lung cancer glucocorticoids (GC) are m...

Descripción completa

Detalles Bibliográficos
Autores principales: Merk, Verena M., Grob, Leonie, Fleischmann, Achim, Brunner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935384/
https://www.ncbi.nlm.nih.gov/pubmed/36653475
http://dx.doi.org/10.1038/s41435-023-00194-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935384/
https://www.ncbi.nlm.nih.gov/pubmed/36653475
http://dx.doi.org/10.1038/s41435-023-00194-y

Ejemplares similares